Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Diseases and Medications listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.
Neuroendocrine Tumors
Status
ClosedThis fund is temporarily closed to new patients due to lack of sufficient funding. Please continue to visit our Disease Funds page often, as replenished funds reopen as quickly as possible. If you currently have a grant with HealthWell, your grant will remain active for the entire 12 month grant cycle or until you have exhausted your allocated grant amount, whichever comes first. You can continue to use your pharmacy card or submit requests for reimbursements during your designated grant cycle.
Assistance Type
Prescription Drug Copayor
Insurance premium (Medicare Part B only)
Maximum Award Level
Pharmacy Card Fund
YesMinimum Copay Reimbursement Amount
We encourage you to please use your HealthWell pharmacy card for any applicable charges as possible.
Minimum Premium Reimbursement Amount
Household Income Limit
500% of the Federal Poverty Level(adjusted for household size and high cost of living areas)
Treatments Covered
- Adriamycin
- Afinitor
- Aldactone
- Alferon N
- Augtyro
- Avelumab
- Bavencio
- Belzutifan
- Cabometyx
- Cabozantinib Malate
- Camptosar
- Capecitabine
- Carboplatin
- Cardura
- Carospir
- Catapres-tts
- Cisplatin
- Clebidipine Butyrate
- Cleviprex
- Clonidine
- Clonidine Hcl
- Cometriq
- Cortef
- Cyclophosphamide
- Dabrafenib Mesylate
- Dacarbazine
- Demser
- Diazoxide
- Dibenzyline
- Doxazosin Mesylate
- Doxorubicin Hydrochloride
- Duraclon
- Ellence
- Entrectinib
- Epirubicin Hydrochloride
- Eplerenone
- Etopophos
- Etoposide Phosphate
- Everolimus
- Fluorouracil
- Frindovyx
- Fusilev
- Hemangeol
- Hycamtin
- Hydrocortisone
- Hydrocortisone Sodium Succinate
- Imlygic
- Inderal La
- Innopran Xl
- Inspra
- Interferon Alfa-n3
- Ipilimumab
- Irinotecan Hydrochloride
- Isturisa
- Kemoplat
- Keytruda
- Khapzory
- Labetalol Hydrochloride
- Lanreotide
- Lanreotide Acetate
- Larotrectinib
- Leucovorin Calcium
- Levoleucovorin
- Levoleucovorin Calcium
- Lutathera
- Lutetium Lu 177 Dotatate
- Lysodren
- Medrol
- Mekinist
- Methylprednisolone
- Methylprednisolone Sodium Succinate
- Metyrosine
- Minipress
- Mitotane
- Mycapssa
- Nexiclon Xr
- Nivolumab
- Nivolumab And Hyaluronidase-nvhy
- Octreotide Acetate
- Onyda Xr
- Opdivo
- Opdivo Qvantig
- Osilodrostat
- Oxaliplatin
- Paraplatin
- Pasireotide
- Pasireotide Diaspartate
- Pazopanib Hydrochloride
- Pembrolizumab
- Phenoxybenzamine Hydrochloride
- Phentolamine Mesylate
- Prazosin Hydrochloride
- Proglycem
- Propranolol
- Repotrectinib
- Retevmo
- Retifanlimab-dlwr
- Rozlytrek
- Sandostatin
- Sandostatin Lar Depot
- Selpercatinib
- Signifor
- Signifor Lar
- Solu-cortef
- Solu-medrol
- Somatuline Depot
- Spironolactone
- Streptozocin
- Sunitinib Malate
- Sutent
- Tafinlar
- Talimogene Laherparepvec
- Telotristat Ethyl
- Temodar
- Temozolomide
- Terazosin Hydrochloride
- Topotecan Hydrochloride
- Trametinib
- Vincristine Sulfate
- Vitrakvi
- Votrient
- Welireg
- Xeloda
- Xermelo
- Yervoy
- Zanosar
- Zynyz
Fund Definition
Assistance with the prescription drugs and biologics used in the treatment of Neuroendocrine tumors.
Grant Utilization
HealthWell estimates that patients use an average of $4,064 during their 12-month grant period for this disease area.
Do I Qualify?
HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:
-
-
To qualify for copayment assistance from HealthWell, you must have some form of health insurance (private insurance, Medicare, Medicaid, TriCare, etc.) that covers part of the cost of your treatment. Please note that in order to qualify for premium assistance through this fund, you must have Medicare Part B. The Foundation will refer patients without prescription insurance to other programs, such as manufacturer patient assistance programs.
-
HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
-
If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.
About Neuroendocrine Tumors
Neuroendocrine tumors (NETs) are rare, often slow-growing, tumors that begin in neuroendocrine cells and can occur anywhere in the body. The most common sites for NETs to occur are the digestive system, lungs, and pancreas, and can spread (metastasize) to other parts of the body. NETs can be difficult to diagnosis as symptoms can mimic other diseases. Symptoms can include abdominal pain, flushing, diarrhea, heart palpitations, changes in weight, high or low blood pressure, and wheezing, among others. Many patients are mis-diagnosed and treated for the wrong disease for up to 5 years. Early diagnosis and proper treatment of NETs are critical to favorable outcomes. NET diagnoses are increasing by more than 5 percent annually and as many as 175,000 patients are living in the United States.
Additional Educational Resources
You may also visit our Resource List to view other copayment organizations that may provide assistance.
